QIAGEN plans to resubmit EUA submission in the U.S. for QIAreach SARS CoV-2 Antigen Test in the first quarter of 2021

QIAGEN confirms effectiveness of its SARS-CoV-2 PCR tests in the face of mutations of the coronavirus

QIAGEN Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute

QIAGEN announces appointment of new Supervisory Board member

QIAGEN launches portable digital SARS-CoV-2 antigen test that can accurately analyze over 30 samples per hour

QIAGEN announces start of share repurchase for up to $100 million

QIAGEN launches NeuMoDx multiplex test to complete range of SARS-CoV-2 testing solutions in Europe and other markets

QIAGEN collaborates with BioNTech on companion diagnostics development for HPV-associated squamous cell carcinoma of the head and neck

QIAGEN to launch QuantiFERON SARS-CoV-2 for research into causes, spread and control of COVID-19 through T-cell response

QIAGEN increases outlook for 2020 and 2021